CMS has withdrawn 2026 skin substitute LCDs. Alliance Mobile Medical Services remains committed to healing wounds - not just managing them.

Over the past year, the wound care industry has experienced one of the most significant regulatory shifts in decades. Medicare’s updated policies surrounding skin substitute grafts and advanced wound care products have fundamentally changed how care is delivered, documented, and reimbursed.

While change of this magnitude is never easy, it is important to be honest about what this moment represents: a reset — and ultimately, a healthier future for patients and ethical providers alike.

What Changed — And Why It Matters

Medicare’s revisions to coverage and reimbursement for skin substitute products were designed to address long-standing concerns around overutilization, inconsistent outcomes, and billing practices that prioritized volume over healing. For years, loopholes in reimbursement structures allowed certain providers to focus more on product usage than patient outcomes.

As a result of these changes, many wound care companies that were built primarily around skin graft billing have struggled to survive.

Industry analysts and regional market data suggest that:

• Nationally, an estimated 20–30% of wound care entities focused heavily on skin substitute revenue have exited the market or significantly downsized

• In Texas — one of the most saturated wound care markets in the country — closures and consolidations are estimated to be even higher, approaching one in three operations in certain metro areas

These were not failures of medicine - they were failures of business models that were never designed to withstand accountability.

Why This Is Actually Good for Patients

While headlines may focus on disruption, what’s happening beneath the surface is far more encouraging.

This shift:

• Removes financial incentives that rewarded overuse

• Elevates the importance of clinical justification and outcomes

• Forces innovation in treatment pathways

• Encourages investment in evidence-based healing, not just product placement

In short, it separates wound care practices that exist to bill from those that exist to heal.

And that distinction matters.

We Are Here to Stay — And to Lead the Change

At Alliance Mobile Medical Services, this transition has only strengthened our mission.

As our CEO, Jeffrey Combs, says:

“Our focus is to heal wounds, not just manage them.”

That philosophy guides every clinical decision we make.

Rather than relying on a single product or reimbursement category, we continuously evaluate:

• The newest evidence-based wound healing technologies

• Advanced biological and non-biological therapies

• Holistic treatment plans that address vascular status, nutrition, mobility, and comorbidities

• Documentation and compliance that withstand audits - because good care should always stand up to scrutiny

This moment in healthcare isn’t about doing less.
It’s about doing better.

A Stronger Industry Is Emerging

The wound care industry is not shrinking — it’s maturing.

Providers who remain are those committed to:

• Ethical medicine

• Long-term patient outcomes

• Clinical excellence over shortcuts

• Sustainable, compliant care models

That’s how trust is rebuilt - with patients, payors, and referral partners.

Proudly Serving Texas Communities

Alliance Mobile Medical Services currently provides mobile wound care across:

• DFW Metroplex and surrounding cities

• San Antonio / New Braunfels

• The Greater Houston Area

We meet patients where they are - at home, in facilities, and within their communities - delivering care that is compassionate, compliant, and relentlessly focused on healing.

Looking Forward

Change can feel uncomfortable - but it is often the sign of progress.

Medicare’s policy updates are not the end of advanced wound care.
They are the beginning of a more accountable, innovative, and patient-centered era.

And we are proud to be part of building what comes next.